Coronavirus Outbreak

FDA Gives EUAs to Three Companies’ Covid-19 Antibodies Tests

June 5, 2020, 9:41 PM

Hangzhou Biotest Biotech was granted emergency use authorization by the FDA for its SARS-CoV-2 antibodies test, according to postings on the FDA’s website.

  • Phosphorus Diagnostics gets an EUA for its Covid-19 RT-qPCR test
  • Vibrant America Clinical gets an EUA for its SARS-CoV-2 antibodies test
  • NOTE: The three EUAs were issued June 4

To view the source of this information click here

To contact the reporter on this story:
Andres Guerra Luz in New York at aluz8@bloomberg.net

To contact the editors responsible for this story:
Chakradhar Adusumilli at cadusumilli@bloomberg.net

Linly Lin

© 2020 Bloomberg L.P. All rights reserved. Used with permission.

To read more articles log in.